Kerk et al. reported that CAFs can activate glutamate-oxaloacetate transaminase 2 (GOT2) in pancreatic ductal adenocarcinoma (PDAC) by supplying pyruvate, thereby rescuing GOT2 deletion-mediated growth inhibition in PDAC cells 30. Here, GOT2 is linked to pancreatic ductal adenocarcinoma.